FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology, and can be used in treating soft tissue sarcomas for the prediction of recurrences. Substance of the invention consists in testing the cells expressing EGFR, CD 34, bcl 6, bcl 2, and if the cells with EGFR, CD 34, bcl 6, bcl 2 hyperexpression are determined , the short-term recurrence is predicted, while the cells with weak EGFR, CD 34, bcl 6, bcl 26 expression enables predicting the favourable outcome.
EFFECT: method provides the higher accuracy and information value of the prediction of recurrent soft tissue sarcomas.
2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE DURATION OF THE RELAPSE-FREE PERIOD OF SOFT TISSUE SARCOMAS OF THE EXTREMITIES IN MIDDLE-AGED AND ELDERLY WOMEN | 2022 |
|
RU2778616C1 |
| METHOD FOR PREDICTING UVEAL MELANOMA METASTASIS SPREAD WITH APOPTOSIS MARKERS BAX AND BCL-2 | 2003 |
|
RU2244934C2 |
| METHOD FOR PREDICTING METASTASES OF UVEAL MELANOMA BASED UPON APOPTOSIS MARKERS BAX AND BCL-2 | 2003 |
|
RU2242766C1 |
| METHOD OF PREDICTING RECURRENT SOFT TISSUE SARCOMAS | 2016 |
|
RU2625035C1 |
| METHOD FOR PREDICTION OF METASTASES IN PATIENTS WITH STOMACH CANCER | 2010 |
|
RU2445632C1 |
| METHOD OF PREDICTION OF CLINICAL COURSE OF UVEA MELANOMA BASED ON APOPTHOSIS MARKER Bax | 2002 |
|
RU2208790C1 |
| METHOD FOR PREDICTING UVEAL MELANOMA METASTASIS FORMATION ON THE BASIS OF BAX AND KI-67 MARKERS | 2003 |
|
RU2240560C1 |
| METHOD FOR PREDICTION OF RISK OF SQUAMOUS METAPLASIA IN RESPIRATORY BRONCHIAL EPITHELIUM WITH DETECTED ISOLATED BASAL CELL HYPERPLASIA | 2012 |
|
RU2538642C2 |
| METHOD PREDICTING CLINICAL COURSE OF UVEA MELANOMA BASED ON APOPTHOSIS MARKER p53 | 2002 |
|
RU2208789C1 |
| METHOD FOR PREDICTION OF ONSET OF LOCAL RECURRENCES IN SURGICAL SCARS IN UNICENTRIC INVASIVE DUCT BREAST CANCER IN PATIENTS WITH PRESERVED MENSTRUAL FUNCTION | 2012 |
|
RU2486518C1 |
